The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world safety and effectiveness of avelumab in immune-compromised (IC) and non-IC patients with Merkel cell carcinoma (MCC): Results from a prospective German registry (MCC-TRIM).
 
Jurgen Becker
Consulting or Advisory Role - 4SC; Almirall; Boehringer Ingelheim; ICON Clinical Research; InProTher; Pfizer; Regeneron; Sanofi
Speakers' Bureau - Amgen; Merck KGaA; Pfizer; Recordati; Sanofi
Research Funding - Alcedis; Bristol-Myers Squibb; HTG Molecular Diagnostics; IQVIA; Merck KGaA
 
Seyed Hamidreza Mahmoudpour
Employment - healthcare business of Merck KGaA, Darmstadt, Germany
Stock and Other Ownership Interests - Bayer
 
Dirk Schadendorf
Honoraria - 4SC; Agenus; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Japan; Erasca, Inc; immatics; Immunocore; InflarxGmbH; LabCorp; Merck Serono; Merck Sharp & Dohme; NeraCare GmbH; Novartis; Novigenix; Pamgene; Pfizer; Philogen; Pierre Fabre; Regeneron; Replimune; Roche/Genentech; Sanofi/Regeneron; Seagen; Sun Pharma; Ultimovacs
Consulting or Advisory Role - Agenus; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Erasca, Inc; immatics; Immunocore; Merck Sharp & Dohme; NeraCare GmbH; Novartis; Pierre Fabre; Replimune; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi/Regeneron
Research Funding - Agenus (Inst); Amgen (Inst); Array BioPharma/Pfizer (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron
 
Ulrike Leiter
Consulting or Advisory Role - Allmiral Hermal; Merck; Novartis; Roche; Sanofi; Sun Pharma
Speakers' Bureau - Merck; Novartis; Roche; Sanofi; Sun Pharma
Research Funding - Merck
 
Friedegund Meier
Honoraria - Bristol-Myers Squibb; Immunocore; MSD; Novartis; Philogen; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore; MSD; Novartis; Philogen; Pierre Fabre; Sanofi
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Immunocore; MSD; Novartis; Pierre Fabre; Sanofi
 
Rudolf Herbst
No Relationships to Disclose
 
Stephan Grabbe
Consulting or Advisory Role - Bristol-Myers Squibb; Klinge Pharma; Kyowa Kirin; Merck; Novartis; Sun Pharma
Research Funding - Novartis; Pierre Fabre
Travel, Accommodations, Expenses - UCB
 
Christoffer Gebhardt
Stock and Other Ownership Interests - Dermagnostix
Consulting or Advisory Role - Almirall; BioNTech; Bristol-Myers Squibb; Immunocore; Merck; Novartis; Pierre Fabre; Sanofi/Regeneron; Sun Pharma
Speakers' Bureau - Almirall; Bristol-Myers Squibb; Janssen; Merck; Novartis; Roche; Sanofi; Sun Pharma; Sysmex
Research Funding - Novartis; Regeneron; Sanofi
 
Fabian Ziller
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma
 
Claudia Pföhler
No Relationships to Disclose
 
Peter Mohr
Honoraria - Bristol-Myers Squibb; Delcat; Merck Sharp & Dohme; Novartis; Pierre Fabre; Regeneron; Sanofi; Sun Pharma Advanced Research Company
Consulting or Advisory Role - Bristol-Myers Squibb; Delcath Systems; Merck Sharp & Dohme; Novartis; Pierre Fabre; Regeneron; Sanofi; Sun Pharma
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis Deutschland LTd (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sun Pharma
 
Lisa Zimmer
Stock and Other Ownership Interests - Bayer
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi; Sun Pharma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi; Sun Pharma
 
Emmanuelle Boutmy
Employment - Merck KGaA
 
Dina Oksen
Employment - Merck KGaA
 
Mairead Kearney
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck; Novartis; UCB
 
Katia Ruth
Employment - Merck KGaA
 
Sebastian Hoff
Employment - Merck KGaA
 
Margarita Shlaen
Employment - IQVIA Commercial GmbH & Co. OHG, Munich, Germany
 
Selma Ugurel
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Merck KGaA; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Merck; Merck KGaA; Novartis
Research Funding - Bristol-Myers Squibb; Merck KGaA
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Pierre Fabre